Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2021-08-10 00:00:00 ET · period of report 2021-08-09 · accession 0001708138-21-000049 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-08-10 | 2021-08-10 | REGN | Van Plew Daniel P | EVP, General Mgr, Industrial | S - Sale+OE | $611.86 | -6,603 | 31.1K | -17% | -$4.04M |
| D | 2021-08-10 | 2021-08-09 | REGN | Van Plew Daniel P | EVP, General Mgr, Industrial | F - Tax | $617.68 | -18.4K | 33.5K | -35% | -$11.36M |
| D | 2021-08-10 | 2021-08-09 | REGN | Van Plew Daniel P | EVP, General Mgr, Industrial | M - OptEx | $270.43 | +25.0K | 51.9K | +93% | +$6.76M |
| D | 2021-08-10 | 2021-08-09 | REGN | Van Plew Daniel P | EVP, General Mgr, Industrial | M - OptEx | $0.00 | -25.0K | 25.0K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-10 | S | D | 300 | $616.27 | 26,931 | D | — | — | (F10) Represents volume-weighted average price of sales of 300 shares of Company stock on August 10, 2021 at prices ranging from $616.01 to $616.51. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 10, 2021 at each separate price. |
| 2 | Common | Common Stock | 2021-08-10 | S | D | 697 | $608.50 | 31,831 | D | — | — | (F3) Represents volume-weighted average price of sales of 697 shares of Company stock on August 10, 2021 at prices ranging from $608.17 to $608.61. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 10, 2021 at each separate price. |
| 3 | Common | Common Stock | 2021-08-10 | S | D | 200 | $609.25 | 31,631 | D | — | — | (F4) Represents volume-weighted average price of sales of 200 shares of Company stock on August 10, 2021 at prices ranging from $609.21 to $609.29. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 10, 2021 at each separate price. |
| 4 | Common | Common Stock | 2021-08-10 | S | D | 100 | $610.81 | 31,531 | D | — | — | |
| 5 | Common | Common Stock | 2021-08-10 | S | D | 762 | $607.21 | 32,528 | D | — | — | (F2) Represents volume-weighted average price of sales of 762 shares of Company stock on August 10, 2021 at prices ranging from $607.00 to $607.84. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 10, 2021 at each separate price. |
| 6 | Common | Common Stock | 2021-08-10 | S | D | 244 | $606.50 | 33,290 | D | — | — | (F1) Represents volume-weighted average price of sales of 244 shares of Company stock on August 10, 2021 at prices ranging from $606.32 to $606.62. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 10, 2021 at each separate price. |
| 7 | Common | Common Stock | 2021-08-09 | F | D | 18,397 | $617.68 | 33,534 | D | — | — | |
| 8 | Common | Common Stock | 2021-08-09 | M | A | 25,000 | $270.43 | 51,931 | D | — | — | |
| 9 | Common | Common Stock | 2021-08-10 | S | D | 280 | $615.22 | 27,231 | D | — | — | (F9) Represents volume-weighted average price of sales of 280 shares of Company stock on August 10, 2021 at prices ranging from $615.00 to $615.45. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 10, 2021 at each separate price. |
| 10 | Common | Common Stock | 2021-08-10 | S | D | 1,120 | $614.33 | 27,511 | D | — | — | (F8) Represents volume-weighted average price of sales of 1,120 shares of Company stock on August 10, 2021 at prices ranging from $614.08 to $614.84. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 10, 2021 at each separate price. |
| 11 | Common | Common Stock | 2021-08-10 | S | D | 1,600 | $613.34 | 28,631 | D | — | — | (F7) Represents volume-weighted average price of sales of 1,600 shares of Company stock on August 10, 2021 at prices ranging from $613.07 to $613.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 10, 2021 at each separate price. |
| 12 | Common | Common Stock | 2021-08-10 | S | D | 900 | $612.45 | 30,231 | D | — | — | (F6) Represents volume-weighted average price of sales of 900 shares of Company stock on August 10, 2021 at prices ranging from $612.03 to $612.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 10, 2021 at each separate price. |
| 13 | Common | Common Stock | 2021-08-10 | S | D | 400 | $611.57 | 31,131 | D | — | — | (F5) Represents volume-weighted average price of sales of 400 shares of Company stock on August 10, 2021 at prices ranging from $611.22 to $611.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 10, 2021 at each separate price. |
| 14 | Derivative | Non-Qualified Stock Option (right to buy) | 2021-08-09 | M | D | 25,000 | $0.00 | 25,000 | D | $270.43 · — to 2023-12-13 | 25,000 Common Stock | (F11) The stock option award vests in four equal annual installments, commencing one year after the date of grant. |